Clinical Trial Update: A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate Dosage [Phase 4]

View source ↗

Summary

Phase 4 study of tocilizumab (RoActemra/Actemra) plus methotrexate in severe active rheumatoid arthritis comparing tapering versus maintaining methotrexate dose…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• RoActemra/Actemra (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 4 | Status: TERMINATED | Results posted: 2016-10-14